CUSIP: 00857U107
Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
415,460,499
-
Total 13F shares
-
371,297,575
-
Share change
-
-9,129,125
-
Total reported value
-
$255,908,991
-
Put/Call ratio
-
14%
-
Price per share
-
$0.69
-
Number of holders
-
195
-
Value change
-
-$10,790,545
-
Number of buys
-
100
-
Number of sells
-
102
Quarterly Holders Quick Answers
What is CUSIP 00857U107?
CUSIP 00857U107 identifies AGL - agilon health, inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Previous quarter:
Q3 2025
Recent filing periods for CUSIP 00857U107:
Institutional Holders of agilon health, inc. - Common Stock (AGL) as of Q4 2025
As of 31 Dec 2025,
agilon health, inc. - Common Stock (AGL) was held by
195 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
371,297,575 shares.
The largest 10 holders included
Clayton, Dubilier & Rice, LLC, MORGAN STANLEY, North Peak Capital Management, LLC, BlackRock, Inc., D. E. Shaw & Co., Inc., GOLDMAN SACHS GROUP INC, VANGUARD GROUP INC, AQR CAPITAL MANAGEMENT LLC, Capital World Investors, and CHARLES SCHWAB INVESTMENT MANAGEMENT INC.
This page lists
195
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.